Assessing efficacy of non‐opioid analgesics in experimental pain models in healthy volunteers: an updated review
- 7 September 2009
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 68 (3), 322-341
- https://doi.org/10.1111/j.1365-2125.2009.03433.x
Abstract
Experimental pain models may help to evaluate the mechanisms of analgesics and target the clinical indications for their use. This review, the second in a series of two, addresses how the efficacy of non-opioid analgesics have been assessed in human volunteers using experimental pain models. A literature search was completed for randomized controlled studies that included human experimental pain models, healthy volunteers and non-opioid analgesics. Nonsteroidal anti-inflammatory drugs worked against various types of acute pain as well as in hyperalgesia. Analgesia from paracetamol was difficult to detect in experimental pain and the pain needed to be assessed with very sensitive methods like evoked brain potentials. The N-methyl-D-aspartate antagonists exemplified by ketamine generally needed strong, long-lasting or repeated pain in the skin for detectable analgesia, whereas pain in muscle and viscera generally was more easily attenuated. Gabapentin worked well in several models, particularly those inducing hyperalgesia, whereas lamotrigine was weak in modulation of experimental pain. Imipramine attenuated pain in most experimental models, whereas amitriptyline had weaker effects. Delta-9-tetrahydrocannabinol attenuated pain in only a few models. Pain induction and assessment are very important for the sensitivity of the pain models. Generally, experimental pain models need to be designed with careful consideration of the pharmacological mechanisms and pharmacokinetics of analgesics. The drawback with the different study designs is also discussed. This knowledge can aid the decisions that need to be taken when designing experimental pain studies for compounds entering Phase I and II trials.This publication has 110 references indexed in Scilit:
- Assessing analgesic actions of opioids by experimental pain models in healthy volunteers – an updated reviewBritish Journal of Clinical Pharmacology, 2009
- Dose-dependent Effects of Smoked Cannabis on Capsaicin-induced Pain and Hyperalgesia in Healthy VolunteersAnesthesiology, 2007
- Multi‐Modal and Tissue‐Differentiated Experimental Pain Assessment: Reproducibility of a New Concept for Assessment of AnalgesicsBasic & Clinical Pharmacology & Toxicology, 2006
- The Analgesic Effect of Tramadol After Intravenous Injection in Healthy Volunteers in Relation to CYP2D6Anesthesia & Analgesia, 2006
- Dose-dependent effects of morphine on experimentally induced cutaneous pain in healthy volunteersPain, 2005
- The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humansPain, 2004
- Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind‐up of the second pain response in healthy male volunteersBritish Journal of Clinical Pharmacology, 2002
- A New Model of Electrically Evoked Pain and Hyperalgesia in Human SkinAnesthesiology, 2001
- Topical acetylsalicylate attenuates capsaicin induced pain, flare and allodynia but not thermal hyperalgesiaNeuroscience Letters, 1996
- Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmakokinetic parametersInflammation Research, 1990